Raj Denhoy
Stock Analyst at Jefferies
(2.96)
# 1,374
Out of 5,238 analysts
46
Total ratings
68.42%
Success rate
27.17%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $84.32 | +42.31% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $79.96 | +62.58% | 10 | Jul 30, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $6.85 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $60.61 | -48.44% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $42.06 | -16.79% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $133.06 | +121.70% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $71.86 | +26.64% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $93.06 | -70.99% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $154.16 | -56.54% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $84.32
Upside: +42.31%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $79.96
Upside: +62.58%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $6.85
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $60.61
Upside: -48.44%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $42.06
Upside: -16.79%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $133.06
Upside: +121.70%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $71.86
Upside: +26.64%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $93.06
Upside: -70.99%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $154.16
Upside: -56.54%